Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shimatsu

Showing results (131-140 of 207) with videos related to

Pageof 21
Sort By:
Biochemical and Biophysical Research Communications|July 6, 2010
Lectin-like oxidized low-density lipoprotein receptor-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese miceRieko Takanabe-Mori, Koh Ono, Naoya Sowa, et al.
Journal of Clinical Biochemistry and Nutrition|December 6, 2017
Prediction of functional profiles of gut microbiota from 16S rRNA metagenomic data provides a more robust evaluation of gut dysbiosis occurring in Japanese type 2 diabetic patientsRyo Inoue, Ryuji Ohue-Kitano, Takamitsu Tsukahara, et al.
Atherosclerosis|November 15, 2008
A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndromeKazuhiko Kotani, Noriko Satoh, Yasuhisa Kato, et al.
Metabolism: Clinical and Experimental|August 30, 2011
Salivary cortisol levels are associated with outcomes of weight reduction therapy in obese Japanese patientsAkihiro Himeno, Noriko Satoh-Asahara, Takeshi Usui, et al.
Pituitary|December 4, 2008
Successful treatment of Cushing's disease caused by ectopic intracavernous microadenomaMitsuteru Koizumi, Takeshi Usui, Shozo Yamada, et al.
Metabolism: Clinical and Experimental|August 24, 2015
Thrombospondin 1 as a novel biological marker of obesity and metabolic syndromeYoshiyuki Matsuo, Masashi Tanaka, Hajime Yamakage, et al.
Diabetes Care|August 28, 2003
Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effectNoriko Satoh, Yoshihiro Ogawa, Takeshi Usui, et al.
Endocrine Journal|June 25, 2009
Predominant expression of mutated allele of the succunate dehydrogenase D (SDHD) gene in the SDHD-related paragangliomasRika Yamashita, Takeshi Usui, Sho Hashimoto, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 16, 2009
A mouse model of ghrelinoma exhibited activated growth hormone-insulin-like growth factor I axis and glucose intoleranceHiroshi Iwakura, Hiroyuki Ariyasu, Yushu Li, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 4, 2017
Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathwaysTakayuki Inoue, Masashi Tanaka, Shinya Masuda, et al.
Pageof 21

Showing results (131-140 of 207) with videos related to

Sort By:
Pageof 21
Biochemical and Biophysical Research Communications|July 6, 2010
Lectin-like oxidized low-density lipoprotein receptor-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese miceRieko Takanabe-Mori, Koh Ono, Naoya Sowa, et al.
Journal of Clinical Biochemistry and Nutrition|December 6, 2017
Prediction of functional profiles of gut microbiota from 16S rRNA metagenomic data provides a more robust evaluation of gut dysbiosis occurring in Japanese type 2 diabetic patientsRyo Inoue, Ryuji Ohue-Kitano, Takamitsu Tsukahara, et al.
Atherosclerosis|November 15, 2008
A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndromeKazuhiko Kotani, Noriko Satoh, Yasuhisa Kato, et al.
Metabolism: Clinical and Experimental|August 30, 2011
Salivary cortisol levels are associated with outcomes of weight reduction therapy in obese Japanese patientsAkihiro Himeno, Noriko Satoh-Asahara, Takeshi Usui, et al.
Pituitary|December 4, 2008
Successful treatment of Cushing's disease caused by ectopic intracavernous microadenomaMitsuteru Koizumi, Takeshi Usui, Shozo Yamada, et al.
Metabolism: Clinical and Experimental|August 24, 2015
Thrombospondin 1 as a novel biological marker of obesity and metabolic syndromeYoshiyuki Matsuo, Masashi Tanaka, Hajime Yamakage, et al.
Diabetes Care|August 28, 2003
Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effectNoriko Satoh, Yoshihiro Ogawa, Takeshi Usui, et al.
Endocrine Journal|June 25, 2009
Predominant expression of mutated allele of the succunate dehydrogenase D (SDHD) gene in the SDHD-related paragangliomasRika Yamashita, Takeshi Usui, Sho Hashimoto, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 16, 2009
A mouse model of ghrelinoma exhibited activated growth hormone-insulin-like growth factor I axis and glucose intoleranceHiroshi Iwakura, Hiroyuki Ariyasu, Yushu Li, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|March 4, 2017
Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathwaysTakayuki Inoue, Masashi Tanaka, Shinya Masuda, et al.
Pageof 21